Biovail appoints Senior Vice President and General Counsel.TORONTO, Canada--(BUSINESS WIRE)--Jan. 30, 1996--Biovail Corporation International (AMEX AMEX See: American Stock Exchange , TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). :BVF BVF Biovail Corporation (stock symbol) BVF Berufsverband der Frauenärzte eV (Muenchen, Germany) BVF Bearing Versus Frequency ) today announced the appointment of Kenneth C. Cancellara, Q.C. as Senior Vice President and General Counsel of the Company, a newly created position, effective March 18, 1996. Mr. Cancellara, 49, is a director of the Company and will continue in this capacity. Mr. Cancellara is currently a Partner with the law firm of Cassels Brock and Blackwell where he serves as Chairman of the firm s executive committee. He is also a member of numerous professional associations. Eugene Melnyk Eugene Melnyk (born May 27, 1959 in Toronto, Ontario) is a Canadian businessman of Ukrainian origin who now resides in Barbados. He is the chairman and chief executive officer of Biovail Corporation. , Chairman of the Board of Biovail, commented, Ken s addition to the senior management team of Biovail will be essential to the future growth and success of the Company. Mr. Cancellara has extensive experience in all facets of the law, with a special emphasis on corporate and business litigations. In addition, his long standing relationship with Biovail and his proven expertise in managing the Company s recent complex regulatory and legal matters, will enhance the Company s strategic position as its research pipeline matures toward commercialization. Biovail Corporation International is an international full-service pharmaceutical company, engaged in the formulation, clinical evaluation clinical evaluation Medtalk An evaluation of whether a Pt has symptoms of a disease, is responding to treatment, or is having adverse reactions to therapy , registration and manufacture of drug products utilizing advanced drug delivery technologies. CONTACT: Eugene Melnyk Chairman of the Board Bob Podruzny Chief Financial Officer (416) 285-6000 or Investor Relations Investor relations The process by which the corporation communicates with its investors. : Donna Stein/ Courtney Levi/Cindy Hintelmann Press: Michael McMullan Morgen-Walke Associates (212) 850-5600 |
|
|||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion